Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Matinas Biopharma Holdings, Inc. (MTNB) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.96M |
|
-- |
|
-- |
|
$6.96M |
|
$-6.96M |
|
$-3.38M |
|
$-10.35M |
|
$-10.38M |
|
$-10.35M |
|
$-10.35M |
|
$-10.35M |
|
$-10.38M |
|
$-6.96M |
|
$-6.50M |
|
5.47M |
|
5.47M |
|
$-2.00 |
|
$-2.00 |
|
| Balance Sheet Financials | |
$4.08M |
|
$0.14M |
|
$3.13M |
|
$7.21M |
|
$1.46M |
|
$0.01M |
|
$0.92M |
|
$2.38M |
|
$4.83M |
|
$4.83M |
|
$4.83M |
|
6.41M |
|
| Cash Flow Statement Financials | |
$-7.01M |
|
$0.34M |
|
$3.39M |
|
$7.53M |
|
$4.25M |
|
$-3.29M |
|
$1.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-214.18% |
|
-214.18% |
|
-143.52% |
|
-213.96% |
|
$0.75 |
|
$-1.22 |
|
$-1.28 |
|